The Cannabis Clinician's Lounge: Clinical Perspectives on Cannabis brings medical experts from around the globe to answer your questions about cannabinoids. This is hosted by Mary Clifton, M.D., a board-certified, licensed, internal medicine doctor. She is a best-selling author and consultant and a highly recognized expert and speaker on the impacts and applications of CBD and Cannabis. She is a sought-after speaker with an impressive list of former clients and speaks at major cannabinoid events around the world, including Africa, Europe and Asia. 

On this episode of The Cannabis Clinician's Lounge: Clinical Perspectives on Cannabis, host Mary Clifton, MD speaks with Sherry Yafai, MD, of The Releaf Institute, with a mission is to educate individuals on how to use cannabis products to accomplish their personal goals for medical treatment as well as decrease the number of pharmaceutical medications. This discussion is framed around bettering the symptoms of Parkinson’s disease, be mitigating the muscular effects of Parkinsonism, as well as combatting cognitive symptoms and associated sleep disorders, all with cannabis. Dr. Clifton and Dr. Yates talk about the options for Parkinson’s patients to incorporate cannabinoids into their treatment protocol while considering the nuances of this disease.

Sherry Yafai, MD is a Board Certified Emergency Medicine Physician who transitioned into Cannabis Medicine in 2017. Dr. Sherry currently sits on the Board of the Society of Cannabis Clinicians and Women's Health & Wellness. She offers individual counseling, management of medications in a personalized, private practice. Dr. Sherry believes in empowering patients to participate in their care. Her approach is direct and action-focused. 

[04:06] Why “disrupt” a conventional medicine career in favor of cannabis?

[12:26] Pharmacological and non-pharmacologic approaches for Parkinson’s disease

[16:16] Night and sleep disturbances, and muscle stiffness in Parkinson’s

[23:16] Best consumption methods for Parkinson’s- with age considerations

[30:11] A Parkinson’s Cade Study: Analyzing breakthrough pain

[37:17] Risk evaluation

[47:20] Terpene benefits for Parkinson’s

Keywords: medical cannabis, cannabis, weed, THC, CBD, medical marijuana, mary clifton, dr. mary clifton, parkinsons,Cannabis Clinician's Lounge

DISCLAIMER- This podcast is done in collaboration with the National Association of Cannabis Businesses, Csequence, and cbdandcannabisinfo.com. The information on this podcast is not intended to be a substitute for professional medical advice, diagnosis or treatment.

The Doctor's Lounge: Clinical Perspectives on Cannabis brings medical experts from around the globe to answer your questions about cannabinoids. The Doctor's Lounge is hosted by Mary Clifton, M.D., a board-certified, licensed, internal medicine doctor. She is a best-selling author and consultant and a highly recognized expert and speaker on the impacts and applications of CBD and Cannabis. She is a sought-after speaker with an impressive list of former clients and speaks at major cannabinoid events around the world, including Africa, Europe and Asia. 

On this episode of The Doctor's Lounge: Clinical Perspectives on Cannabis, moderator Zachary Moore, PhD, Senior Director at Csequence, joins host Mary Clifton, MD, and Jeffrey S. Block, MD, a healthcare consultant specializing in botanical medicines and is the founder of Nurturing Nature Group. Today, they discuss all things relating to opioid abuse and how cannabis can mitigate cravings and withdrawals.

Jeffrey S. Block, M.D. is a nationally respected authority in both the health-care and natural earth sciences concerning botanical medicine education and research, and the principal partner  of Nurturing NatureGroup Consultants, a professional independent consultancy providing client organizations with advanced scientific guidance. This industry-wide consultancy provides insight by translating the evolving new science’s evidence-based objective data. These essential analyses benefit a client’s ultimate success by providing knowledge of critical competitive advantages needed to reach performance goals.

[07:50] Current opioid users and its potential misuse

[14:59] Ethics of withdrawal medication combined with cannabis

[22:11] Where to begin looking for specific treatment for back pain

[35:19] The future of legal cannabis prescriptions in substitution for opiates

[42:54] Clinics and their administration of opioids

[46:05] Discussing the chances of ending the national opioid crisis

DISCLAIMER- This podcast is done in collaboration with the National Association of Cannabis Businesses, Csequence, and cbdandcannabisinfo.com. The information on this podcast is not intended to be a substitute for professional medical advice, diagnosis or treatment. 

The Doctor's Lounge: Clinical Perspectives on Cannabis brings medical experts from around the globe to answer your questions about cannabinoids. The Doctor's Lounge is hosted by Mary Clifton, M.D., a board-certified, licensed, internal medicine doctor. She is a best-selling author and consultant and a highly recognized expert and speaker on the impacts and applications of CBD and Cannabis. She is a sought-after speaker with an impressive list of former clients and speaks at major cannabinoid events around the world, including Africa, Europe and Asia. 

On this episode of The Doctor's Lounge: Clinical Perspectives on Cannabis, moderator Zachary Moore, PhD, Senior Director at Csequence, joins host Mary Clifton, MD, and Patricia Frye, MD, an independent physician consultant who sees the value of cannabis and cannabinoid medication and the role they play in homeostasis and the management of pain and chronic disease. She is exceptionally experienced in guiding patients of all ages through the process of adding medicinal cannabis and other evidence-based methods to their therapeutic regimen.

​Dr Patricia Frye is an independent physician consultant who sees the value of cannabis and cannabinoid medication  and the role they play in homeostasis and the management of pain and chronic disease. She is currently evaluating and managing patients who are seeking medicinal cannabis either as a primary or adjunct therapy for illnesses such as chronic pain syndromes, neurodegenerative disorders, gastrointestinal disease, seizures, autoimmune disease, insomnia, cancer, anorexia, and mood disorders. While euphoria can be a respite for patients with high levels of stress or chronic pain, many forms of cannabis are non-impairing and can be beneficial to patients who are looking for symptom relief without the “high”, dizziness, or other side effects associated with Δ9-THC.

[03:22] The endocannabinoid system & the immune system interactions

[11:25] The innate v.s. adaptive immune systems

[16:19] Gastrointestinal autoimmune disorders and modes of administrations

[21:19] When smoking isn’t ideal as a mode of delivery 

[31:25] Classes of medications that may contraindicated cannabis

[40:15] CBD and its iterations in inflammatory skin conditions

DISCLAIMER- This podcast is done in collaboration with the National Association of Cannabis Businesses, Csequence, and cbdandcannabisinfo.com. The information on this podcast is not intended to be a substitute for professional medical advice, diagnosis or treatment.